25 Feb Eylea Best for Diabetic Macular Edema | Treatment for DME
Eylea, Lucentis and Avastin are compared head to head. Eylea is best for patients with moderate vision loss or worse....
Eylea, Lucentis and Avastin are compared head to head. Eylea is best for patients with moderate vision loss or worse....
The FDA approved Eylea as a new treatment for wet macular degeneration. Recent reports indicate the drug is similar to Lucentis after the initial year of treatment. Why is this bad news?...
Alimera Sciences suffers set back with Iluvien. In a complete response letter to the company, the FDA did not approve the device for diabetic retinopathy citing concerns over safety....
The American Academy of Ophthalmology starts this week. I will be going to learn about the latest in retinal disease, but also will be teaching...
The first implantable telescope for patients with macular degeneration is now available for those eligible patients. Medicare will endorse as of October, 2011....
The FDA issued an alert that 12 cases of intraocular infection were linked to Avastin. The infections; however, were linked to a single pharmacy and, perhaps, dirty syringes....
VEGF Trap Eye is another anti-VEGF medication to be injected into the eye for the treatment of wet macular degeneration. The FDA did not approve recently, but will reconsider by November!...
Some patients with diabetic retinopathy require two types of treatment. Should treatment for macular edema precede other treatment?...
Ever had an eye injection that hurt? Intraocular injections of Avastin should not hurt, but if it does, ask your doctor to change the preparation....
CATT trial revealed that it appears Avastin is as effective as Lucentis for the treatment of wet ARMD. They are equally safe, too....